drugset / Trial / NCT06433310

Understanding the Efficacy of Dietary Supplement on Fungal Mycobiota in Healthy Volunteers: A Pilot Study

NCT06433310

Phase 4 Recruiting 20 enrolled Weill Medical College of Cornell University
NaSingle-groupOpen-labelBasic science

Summary

The purpose of this study is to explore how the dietary supplement L-Phenylalanine affects the production of the metabolite phenylpropionic acid (PPA) and changes fungal populations of the gut microbiome.

Timeline

Start
2024-10-17
Primary completion
2027-12-17
Completion
2027-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject amino acids Unknown 500 mg Oral

Indications

No indication recorded.